Thursday, April 26, 2018
IBB 103.26 0.01 (0.01%)XBI 86.35 0.1 (0.12%)
Ticker Current Price Change Graph
IBB 103.26 0.01 (0.01%)
XBI 86.35 0.1 (0.12%)
Last updated: ago
Sign in to Endpoints
Menu Search Chat
  • Special Reports
  • Deep Dives
  • ENDPOINTS 100
  • News
  • Protocols
  • Bioregnum
  • Endpoints Careers
  • About
  • Advertise
  • Privacy Policy
  • Reader center

Acadia shares slide — again — after CNN’s report that the FDA has launched a safety review of Nuplazid

by John Carrollenvelope — on April 25, 2018 02:35 PM EDT
Updated: 04:18 PM

Venrock-backed startup Corvidia snags $60M round to develop ex-AstraZeneca drug

by Brittany Meilingenvelope — on April 25, 2018 01:51 PM EDT

After mega-round investment, ADC Therapeutics cans PhI trial in HER2

by Brittany Meilingenvelope — on April 25, 2018 09:23 AM EDT

Daiichi Sankyo concedes an early setback on Duchenne MD drug, but doubles down on development

by John Carrollenvelope — on April 25, 2018 08:21 AM EDT

After decades in the big leagues, Martin Mackay is going small — and he’s delighted

by John Carrollenvelope — on April 25, 2018 07:30 AM EDT

Celldex brings out the ax in wake of breast cancer drug disaster, chopping a quarter of its staff

by Amber Tongenvelope — on April 25, 2018 05:52 AM EDT

‘Site-less’ trials in mind, Novartis launches an app for ophthalmology research

by Brittany Meilingenvelope — on April 24, 2018 11:14 PM EDT

UPDATED: Can Takeda actually close its $65B deal to buy Shire? Maybe, but analysts aren’t sure they should

by John Carrollenvelope — on April 24, 2018 07:39 PM EDT
Updated: April 25, 2018 09:57 AM

Done deal? Takeda reaches a ‘breakthrough’ in Shire merger talks as deal announcement looms — Reuters

by John Carrollenvelope — on April 24, 2018 04:36 PM EDT
Updated: 04:37 PM

Arrested and charged with fraud, PixarBio CEO Frank Reynolds could face up to 20 years in prison

by Amber Tongenvelope — on April 24, 2018 12:43 PM EDT
Updated: 12:47 PM

  • 1
  • 2
  • 3
  • 295

Contact Endpoints News

You can also contact John Carroll, Editor at john@endpointsnews.com

← Go back
  • Endpoints Careers
  • About Endpoints
  • Privacy Policy
  • Advertise/Media Kit

copyright 2018 Endpoints Company

Yes, I'd like to subscribe No, thanks
I'm already a subscriber
Thank you for staying with us. It's great to have you on board!
Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?
Sure No
← Go back

Sign in to Endpoints News

I forgot my password Request a magic link
← Go back

Request a magic link

Enter your email below to get a Magic link which lets you sign in quickly without using a password.
Please note the Magic link is one-time use only and valid for only 24 hours.
← Go back

Set a new password

We will send you a link, with which you will be able to set a new password.
Please note this link is one-time use only and valid for only 24 hours.